Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
4.770
+0.940 (24.54%)
At close: Mar 27, 2026, 4:00 PM EDT
5.05
+0.28 (5.87%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of $27.08 million as of March 27, 2026. Its market cap has increased by 224.59% in one year.
Market Cap
27.08M
Enterprise Value
24.79M
1-Year Change
224.59%
Ranking
Category
Stock Price
$4.77
Market Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from $121.65M to $27.08M, a decrease of -77.74%. That is a compound annual growth rate of -17.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 27.08M | -7.80% |
| Dec 31, 2025 | 29.37M | 321.68% |
| Dec 31, 2024 | 6.96M | -80.54% |
| Dec 29, 2023 | 35.78M | 20.93% |
| Dec 30, 2022 | 29.59M | -29.85% |
| Dec 31, 2021 | 42.18M | 40.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curis | 23.19M |
| XTL Biopharmaceuticals | 23.18M |
| Senti Biosciences | 23.17M |
| Neuphoria Therapeutics | 22.64M |
| Longeveron | 22.64M |
| Marker Therapeutics | 22.51M |
| Barinthus Biotherapeutics | 22.46M |
| Tempest Therapeutics | 22.38M |